Patents
Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
01/2007
01/10/2007EP1740553A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
01/10/2007EP1740540A1 Phenyl acetamides
01/10/2007CN1294274C Enzymatic resolution of t-butyl taxane derivatives
01/09/2007US7160907 Pleuromutilin derivatives
01/09/2007US7160903 Sulfonylaminocarboxylic acids
01/04/2007WO2006073610A3 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
01/03/2007EP1737817A1 Azetidine derivatives, method for producing said derivatives and use thereof
01/03/2007EP1737815A1 Thio-substituted biaryl-methanesulfinyl derivatives
01/03/2007EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
01/03/2007CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases
01/02/2007US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
01/02/2007US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2007US7157447 Useful for treating HIV infection and AIDS
12/2006
12/28/2006WO2006138230A2 The preparation and use of protease inhibitors
12/28/2006WO2006137796A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
12/28/2006WO2006137795A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors useful for the treatment of hyperlipidaemic conditions
12/28/2006WO2006137794A1 New2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
12/28/2006WO2006137791A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
12/28/2006WO2006137782A1 Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia
12/28/2006WO2006137080A1 Improved process for the preparation of ezetimibe
12/28/2006US20060293299 3-((1S)-1-{1-[(S)-(3-cyanophenyl)(4-cyanophenyl)methyl]azetidin-3-yl}-2-fluoro-2-methylpropyl)-5-fluorobenzonitrile and its salts; antagonists and inverse agonists of the Cannabinoid-1 receptor
12/28/2006CA2613239A1 Improved process for the preparation of ezetimibe
12/28/2006CA2611142A1 Anti-hypercholesterolemic compounds
12/28/2006CA2610890A1 Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia
12/28/2006CA2610617A1 The preparation and use of protease inhibitors
12/28/2006CA2609994A1 New2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
12/28/2006CA2609993A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
12/27/2006EP1735270A1 Diamino alcohols and their use as renin inhibitors
12/27/2006EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
12/27/2006EP1345895B1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
12/27/2006CN1886369A Process for converting heterocyclic ketones to amido-substituted heterocycles
12/27/2006CN1291975C New mandelic acid derivatives and their use as thrombase inhibitors
12/21/2006US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/21/2006DE102004025071B4 Verfahren zur Herstellung von Diphenylazetidinon-Derivaten Process for the preparation of derivatives diphenylazetidinone
12/21/2006CA2610442A1 Beta-lactam synthesis
12/21/2006CA2610411A1 Resolution of enantiomeric mixtures of .beta.-lactams
12/20/2006EP1456171B1 Substituted cyclohexane derivatives
12/20/2006CN1882577A 喹唑啉衍生物 Quinazoline derivatives
12/19/2006CA2158863C Taxanes having a pyridyl substituted side-chain
12/14/2006WO2006102674A3 Diphenylheterocycle cholesterol absorption inhibitors
12/14/2006US20060281918 Resolution of enantiomeric mixtures of beta-lactams
12/14/2006US20060281728 3-Substituted beta-lactamyl vasopressin v1a antagonists
12/14/2006US20060281727 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes
12/13/2006EP1483241A4 Cyclic derivatives as modulators of chemokine receptor activity
12/13/2006CN1878770A Novel hypocholesterolemic compounds
12/13/2006CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/12/2006US7148259 hydroxyamidines; antibiotic resistance
12/12/2006US7148251 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
12/06/2006EP1727793A1 Substituted azetidine compounds as cyclooxygenase-1 - cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
12/06/2006CN1874991A Compound capable of binding S1P receptor and pharmaceutical use thereof
12/06/2006CN1872854A Antibiotic in lactam class, and prepartion method
11/2006
11/30/2006WO2006127893A2 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
11/30/2006US20060270651 Antibacterial agents
11/30/2006US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006US20060270613 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid, for example; antilipemic agents; anticholesterol agents
11/30/2006CA2609506A1 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
11/29/2006CN1870990A Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/29/2006CN1870988A 2-azetidinones as anti-hypercholesterolemic agents
11/28/2006US7141570 antimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium
11/28/2006CA2155018C C7 taxane derivatives and pharmaceutical compositions containing them
11/23/2006US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006US20060264435 Novel compounds
11/22/2006EP1429756B1 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
11/22/2006EP1392287B1 Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
11/16/2006WO2006122117A2 Organometal benzenephosphonate coupling agents
11/16/2006WO2006121822A1 USE OF β-LACTAMS FOR THE TREATMENTOF IBD AND GLAUCOMA
11/16/2006WO2006121708A1 Substituted beta-lactams and their use in medicine
11/16/2006CA2607939A1 Process for production of 4-biphenylyazetidin-2-ones
11/16/2006CA2602535A1 Substituted beta-lactams and their use in medicine
11/15/2006EP1720550A1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
11/14/2006US7135479 Compounds which are both serotonin reuptake inhibitors and antagonists of the 5HT1A receptor
11/09/2006WO2006118307A1 Therapeutic agent for pain
11/09/2006US20060252929 Novel intermediate for carbapenem compound for oral administration and process for producing the same
11/09/2006US20060252742 prostaglandin receptor agonists; for treating various ocular hypertensive conditions such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
11/08/2006EP1718609A1 Substituted azetidine compounds, their preparation and use as medicaments
11/08/2006EP1718604A1 Immunosuppressant compounds and compositions
11/08/2006EP1718307A2 Immunosuppressant compounds and compositions
11/07/2006US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome
11/07/2006US7132415 Especially a substituted azetidinone compound
11/07/2006US7132414 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/31/2006US7129233 Competitive and selective inhibitors of trypsin-like serine proteases involved in hemostasis; anticoagulants; e.g., 1-((1-haloalkoxy)phenyl)-),2-(hydroxy),ethyl)carbonyl-),2-((4-amidinopyrid-1-yl)methaminocarbonyl)pyrrole
10/31/2006US7129228 Heterocyclic analgesic compounds and methods of use thereof
10/26/2006US20060241179 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
10/25/2006EP1265606B1 Cell adhesion inhibitors
10/24/2006US7126003 Enzyme hydrolysis of ester
10/19/2006US20060234996 Novel crystalline form of ezetimibe and processes for the preparation thereof
10/18/2006EP1711463A2 Amino-substituted tricyclic derivatives and methods of use
10/18/2006EP1345932B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
10/18/2006CN1849302A 1, 3-disubstituted azetidine derivatives for use as CCR-3 receptor antagonists in the treatment of inflammatory and allergic diseases
10/18/2006CN1280267C Sulfonylaminocarboxylic acids
10/12/2006WO2006060225A3 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds
10/12/2006CA2648522A1 Substituted azetidinones
10/11/2006EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/10/2006US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
10/10/2006CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
10/04/2006CN1277819C Process for producing azetidinone compounds
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006US7115607 Substituted piperazinyl amides and methods of use
09/2006
09/28/2006WO2006102674A2 Diphenylheterocycle cholesterol absorption inhibitors
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 69